Live Breaking News & Updates on Africa Genomic Research Approach For Diversity

Stay updated with breaking news from Africa genomic research approach for diversity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

GSK and Novartis Announce Funding for Scientific Research in Africa

–Combined funding commitment of GBP 2.8 million (USD 3.6 million) over five years
GSK and Novartis yesterday announced the launch of a collaboration to support high-quality scientific research investigating the link between genetic diversity across different regions in Africa and its potential impact on response to drug therapeutics.
The Project Africa Genomic Research Approach for Diversity and Optimising Therapeutics (GRADIENT), with a combined funding commitment of GBP 2.8m (USD 3.6 million) over five years, calls on African researchers to submit robust research proposals on the relevance of African genetic diversity to the treatment of malaria and tuberculosis.1
Pauline Williams, Senior Vice President Global Health Pharma at GSK said: “At GSK, human genetics is a core pillar of our R&D strategy. Genetic diversity is greater in Africa than in any other continental population resulting in some African patients having varying response to treatments. We are excited ....

Lutz Hegemann , Pauline Williams , Glenda Gray , Global Health Pharma , Novartis Institutes For Biomedical Research On African , Steering Committee , Global Health At Novartis , Africa Medical Research Council , African Medical Research Council , Africa Genomic Research Approach For Diversity , Project Africa Genomic Research Approach , Optimising Therapeutics , Senior Vice President Global Health Pharma , Project Africa , Chief Operating Officer , Global Health , South African Medical Research Council , Joint Steering Committee , South Africa Medical Research Council , Open Lab , Sub Saharan African , Novartis Institutes , Biomedical Research , லூட்ஸ் ெகேமன்ன் , பாலீந் வில்லியம்ஸ் , க்லெஂட சாம்பல் ,

Novartis, GSK team up for $3.6m genetic diversity research in Africa

Novartis, GSK team up for $3.6m genetic diversity research in Africa
pharmaceutical-business-review.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmaceutical-business-review.com Daily Mail and Mail on Sunday newspapers.

Lutz Hegemann , Pauline Williams , Global Health Pharma , Steering Committee , Novartis Global Health , Africa Genomic Research Approach For Diversity , African Medical Research Council , Africa Genomic Research Approach , Optimizing Therapeutics , Project Africa , Global Health , South African Medical Research Council , Joint Steering Committee , Health Pharma , Cadent Therapeutics , லூட்ஸ் ெகேமன்ன் , பாலீந் வில்லியம்ஸ் , உலகளாவிய ஆரோக்கியம் பார்மா , திசைமாற்றி குழு , நோவர்த்திச் உலகளாவிய ஆரோக்கியம் , மேம்படுத்துகிறது சிகிச்சை , உலகளாவிய ஆரோக்கியம் , கூட்டு திசைமாற்றி குழு , ஆரோக்கியம் பார்மா ,

Novartis and GSK announce collaboration to support scientifi

ng
Therapeutics (GRADIENT), with a combined funding commitment of GBP 2.8 million (USD 3.6 million) over five years, calls on African researchers to submit robust research proposals on the relevance of African genetic diversity to the treatment of malaria and tuberculosis (TB).
1
Lutz Hegemann, M.D., Chief Operating Officer for Global Health at Novartis said: “Novartis has a long-standing commitment to improving and extending the lives of patients around the world. Our efforts include seeking innovative ways to improve the standard of care where possible. This is why we are excited by this important collaboration on scientific research on genetic diversity in Africa. It has the potential to improve the efficacy and tolerability of current and future medicines, starting with two of the most deadly diseases, malaria and tuberculosis. In alignment with our ongoing efforts to strengthen scientific capabilities in lower-resource settings, this project also provides op ....

United States , Isabella Zinck , Eric Althoff , Thomas Hungerbuehler , Kara Cournoyer , Glenda Gray , Samir Shah , Lutz Hegemann , Sloan Simpson , Katerina Kontzalis , Antonio Ligi , Pauline Williams , Novartis Global Health Corporate Responsibility , Global Health Pharma , Novartis Institutes For Biomedical Research , Novartis Institutes For Biomedical Research On African , Steering Committee , Global Health At Novartis , Global Health Cr Communications , Novartis Us External Communications , Novartis External Communications , Exchange Commission , Africa Medical Research Council , African Medical Research Council , Africa Genomic Research Approach For Diversity , Project Africa Genomic Research Approach ,

Norvatis partners with GSK to support scientific research in Africa

GSK, and its Swiss counterpart, Novartis, has announced the launch of a collaboration to support high-quality scientific research. ....

United Kingdom , Pauline Williams , Glenda Gray , Global Health Pharma , Steering Committee , Africa Genomic Research Approach For Diversity , African Medical Research Council , Project Africa Genomic Research Approach , Optimising Therapeutics , Senior Vice President Global Health Pharma , Project Africa , South African Medical Research Council , Joint Steering Committee , ஒன்றுபட்டது கிஂக்டம் , பாலீந் வில்லியம்ஸ் , க்லெஂட சாம்பல் , உலகளாவிய ஆரோக்கியம் பார்மா , திசைமாற்றி குழு , மூத்தவர் துணை ப்ரெஸிடெஂட் உலகளாவிய ஆரோக்கியம் பார்மா , கூட்டு திசைமாற்றி குழு ,

GSK and Novartis announce collaboration to support scientific research into genetic diversity in Africa

ng
Therapeutics (GRADIENT), with a combined funding commitment of GBP 2.8m (USD 3.6 million) over five years, calls on African researchers to submit robust research proposals on the relevance of African genetic diversity to the treatment of malaria and tuberculosis.
1
Pauline Williams, Senior Vice President Global Health Pharma at GSK said: “At GSK, human genetics is a core pillar of our R&D strategy. Genetic diversity is greater in Africa than in any other continental population resulting in some African patients having varying response to treatments. We are excited to launch Project Africa GRADIENT which aims to catalyse the best science in the continent to optimize treatment responses for malaria and tuberculosis, two infectious diseases that disproportionately affect African populations.” ....

United Kingdom , Nairobi Area , United States , City Of , Simon Moore , Thomas Hungerbuehler , Jeff Mclaughlin , Simon Steel , Danielle Smith , Glenda Gray , Samir Shah , Lutz Hegemann , Ben Agina , Antonio Ligi , Sarah Elton Farr , Isabella Zinck , Evan Berland , Eric Althoff , Kara Cournoyer , Omongiade Ehighebolo , James Dodwell , Cory Twining , Sloan Simpson , Katerina Kontzalis , Pauline Williams , Novartis Global Health Corporate Responsibility ,